1-20 of 26
Glenn Dranoff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade

Xiaoyu Li, Jingjing Li, Yue Zheng, Sandra J. Lee, Jun Zhou, Anita Giobbie-Hurder, Lisa H. Butterfield, Glenn Dranoff, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (8): 1100–1113.
https://doi.org/10.1158/2326-6066.CIR-22-0702
Published: 03 August 2023
View article titled, Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade
Open the PDF for Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses

Rohan Diwanji, Neil A. O'Brien, Jiyoung E. Choi, Beverly Nguyen, Tyler Laszewski, Angelo L. Grauel, Zheng Yan, Xin Xu, Jincheng Wu, David A. Ruddy, Michelle Piquet, Marc R. Pelletier, Alexander Savchenko, LaSalette Charette, Vanessa Rodrik-Outmezguine, Jason Baum, John M. Millholland, Connie C. Wong, Anne-Marie Martin, Glenn Dranoff, Iulian Pruteanu-Malinici, Viviana Cremasco, Catherine Sabatos-Peyton, Pushpa Jayaraman
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (6): 777–791.
https://doi.org/10.1158/2326-6066.CIR-22-0290
Published: 02 June 2023
View article titled, Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses
Open the PDF for Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses in another window
Includes: Supplementary data
Journal Articles

Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies

Filip Janku, Sae-Won Han, Toshihiko Doi, Alessio Amatu, Jaffer A. Ajani, Yasutoshi Kuboki, Alex Cortez, Susan E. Cellitti, Ping C. Mahling, Kulandayan Subramanian, Heidi A. Schoenfeld, Sarah M. Choi, Lori A. Iaconis, Lang Ho Lee, Marc R. Pelletier, Glenn Dranoff, Vasileios Askoxylakis, Salvatore Siena
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (12): 1441–1461.
https://doi.org/10.1158/2326-6066.CIR-21-0722
Published: 02 December 2022
View article titled, Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2<sup>+</sup> Malignancies
Open the PDF for Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2<sup>+</sup> Malignancies in another window
Includes: Supplementary data
Journal Articles

A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy

Si-Qi Liu, Alyssa Grantham, Casey Landry, Brian Granda, Rajiv Chopra, Srinivas Chakravarthy, Sabine Deutsch, Markus Vogel, Katie Russo, Katherine Seiss, William R. Tschantz, Tomas Rejtar, David A. Ruddy, Tiancen Hu, Kimberly Aardalen, Joel P. Wagner, Glenn Dranoff, Joseph A. D'Alessio
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2021) 9 (1): 34–49.
https://doi.org/10.1158/2326-6066.CIR-20-0080
Published: 04 January 2021
View article titled, A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy
Open the PDF for A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract A76: Anti IL-1b as a cancer immunotherapy

Reshma Singh, Rohan Diwanji, Pushpa Jayaraman, Derek Chiang, Catherine Sabatos-Peyton, Glenn Dranoff
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): A76.
https://doi.org/10.1158/2326-6074.TUMIMM18-A76
Published: 01 April 2020
View article titled, Abstract A76: Anti IL-1b as a cancer immunotherapy
Journal Articles

Abstract B79: Proinflammatory cytokine profile of syngeneic models

Jolanta Dubauskaite, Laura Bradshaw, Ashley Merlino, Xianhui Rong, Connie Gee, Glenn Dranoff, Maria Pinzon-Ortiz
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): B79.
https://doi.org/10.1158/2326-6074.TUMIMM18-B79
Published: 01 April 2020
View article titled, Abstract B79: Proinflammatory cytokine profile of syngeneic models
Journal Articles

Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

Susanne H. Baumeister, Joana Murad, Lillian Werner, Heather Daley, Helene Trebeden-Negre, Joanina K. Gicobi, Adam Schmucker, Jake Reder, Charles L. Sentman, David E. Gilham, Frédéric F. Lehmann, Ilene Galinsky, Heidi DiPietro, Kristen Cummings, Nikhil C. Munshi, Richard M. Stone, Donna S. Neuberg, Robert Soiffer, Glenn Dranoff, Jerome Ritz, Sarah Nikiforow
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (1): 100–112.
https://doi.org/10.1158/2326-6066.CIR-18-0307
Published: 02 January 2019
View article titled, Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
Open the PDF for Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors

Viviana Cremasco, Jillian L. Astarita, Angelo L. Grauel, Shilpa Keerthivasan, Kenzie MacIsaac, Matthew C. Woodruff, Michael Wu, Lotte Spel, Stephen Santoro, Zohreh Amoozgar, Tyler Laszewski, Sara Cruz Migoni, Konstantin Knoblich, Anne L. Fletcher, Martin LaFleur, Kai W. Wucherpfennig, Ellen Pure, Glenn Dranoff, Michael C. Carroll, Shannon J. Turley
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2018) 6 (12): 1472–1485.
https://doi.org/10.1158/2326-6066.CIR-18-0098
Published: 03 December 2018
View article titled, FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors
Open the PDF for FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors in another window
Includes: Supplementary data
Journal Articles

PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF

Girija Goyal, Karrie Wong, Christopher J. Nirschl, Nicholas Souders, Donna Neuberg, Niroshana Anandasabapathy, Glenn Dranoff
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (6): 723–732.
https://doi.org/10.1158/2326-6066.CIR-17-0612
Published: 31 May 2018
View article titled, PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF
Open the PDF for PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF in another window
Includes: Supplementary data
Journal Articles

IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

Eleanor Clancy-Thompson, Lestat Ali, Patrick T. Bruck, Mark A. Exley, Richard S. Blumberg, Glenn Dranoff, Michael Dougan, Stephanie K. Dougan
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (1): 25–35.
https://doi.org/10.1158/2326-6066.CIR-17-0490
Published: 02 January 2018
View article titled, IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells
Open the PDF for IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells in another window
Includes: Supplementary data
Journal Articles

Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes

Xinqi Wu, Jingjing Li, Erin M. Connolly, Xiaoyun Liao, Jing Ouyang, Anita Giobbie-Hurder, Donald Lawrence, David McDermott, George Murphy, Jun Zhou, Matthias Piesche, Glenn Dranoff, Scott Rodig, Margaret Shipp, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (6): 446–454.
https://doi.org/10.1158/2326-6066.CIR-16-0385
Published: 01 June 2017
View article titled, Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
Open the PDF for Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes in another window
Includes: Supplementary data
Journal Articles

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade

Jun Zhou, Kathleen M. Mahoney, Anita Giobbie-Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott Rodig, Jingjing Li, Xinqi Wu, Lisa H. Butterfield, Matthias Piesche, Michael P. Manos, Lauren M. Eastman, Glenn Dranoff, Gordon J. Freeman, F. Stephen Hodi
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2017) 5 (6): 480–492.
https://doi.org/10.1158/2326-6066.CIR-16-0329
Published: 01 June 2017
View article titled, Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Open the PDF for Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

Abstract A56: Identification and characterization of an alternative cancer-derived PDL1 isoform

Nadia B. Hassounah, Samuel Freeman, Ellen M. Beauchamp, Chandra S. Pedamallu, Shohei Koyama, Nicholas Souders, Sunil Martin, Esra A. Akbay, Gordon J. Freeman, Glenn Dranoff, Kwok-Kin Wong, Peter S. Hammerman
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): A56.
https://doi.org/10.1158/2326-6074.TUMIMM16-A56
Published: 28 February 2017
View article titled, Abstract A56: Identification and characterization of an alternative cancer-derived PDL1 isoform
Journal Articles

Abstract IA23: Microenvironmental regulation of antitumor immune responses: A lesson from fibroblastic cells

Viviana Cremasco, Angelo Grauel, Michael Wu, Jillian Astarita, Matthew Woodruff, Zohreh Amoozgar, Lotte Spel, Flavian Brown, Michael Carroll, Kenzie MacIsaac, Glenn Dranoff, Shannon Turley
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): IA23.
https://doi.org/10.1158/2326-6066.IMM2016-IA23
Published: 31 October 2016
View article titled, Abstract IA23: Microenvironmental regulation of antitumor immune responses: A lesson from fibroblastic cells
Journal Articles

Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes

Vishwajith Sridharan, Evisa Gjini, Xiaoyun Liao, Nicole G. Chau, Robert I. Haddad, Mariano Severgnini, Peter Hammerman, Adel El-Naggar, Gordon J. Freeman, F. Stephen Hodi, Scott J. Rodig, Glenn Dranoff, Jonathan D. Schoenfeld
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (8): 679–687.
https://doi.org/10.1158/2326-6066.CIR-16-0031
Published: 31 July 2016
View article titled, Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes
Open the PDF for Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes in another window
Includes: Supplementary data
Journal Articles

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Keith L. Ligon, Scott J. Rodig, Shakti H. Ramkissoon, Kristen L. Jones, Amy Saur Conway, Xiaoyun Liao, Jun Zhou, Patrick Y. Wen, Annick D. Van Den Abbeele, F. Stephen Hodi, Lei Qin, Nancy E. Kohl, Arlene H. Sharpe, Glenn Dranoff, Gordon J. Freeman
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (2): 124–135.
https://doi.org/10.1158/2326-6066.CIR-15-0151
Published: 01 February 2016
View article titled, Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Open the PDF for Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model in another window
Includes: Supplementary data
Journal Articles

Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication

Omar A. Ali, Sarah A. Lewin, Glenn Dranoff, David J. Mooney
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2016) 4 (2): 95–100.
https://doi.org/10.1158/2326-6066.CIR-14-0126
Published: 01 February 2016
View article titled, Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication
Open the PDF for Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication in another window
Includes: Supplementary data
Journal Articles

MicroRNA MIR21 and T Cells in Colorectal Cancer

Kosuke Mima, Reiko Nishihara, Jonathan A. Nowak, Sun A. Kim, Mingyang Song, Kentaro Inamura, Yasutaka Sukawa, Atsuhiro Masuda, Juhong Yang, Ruoxu Dou, Katsuhiko Nosho, Hideo Baba, Edward L. Giovannucci, Michaela Bowden, Massimo Loda, Marios Giannakis, Adam J. Bass, Glenn Dranoff, Gordon J. Freeman, Andrew T. Chan, Charles S. Fuchs, Zhi Rong Qian, Shuji Ogino
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1): 33–40.
https://doi.org/10.1158/2326-6066.CIR-15-0084
Published: 03 January 2016
View article titled, MicroRNA <em>MIR21</em> and T Cells in Colorectal Cancer
Open the PDF for MicroRNA <em>MIR21</em> and T Cells in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract IA25: Mechanisms of protective tumor immunity

Glenn Dranoff
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): IA25.
https://doi.org/10.1158/2326-6074.TUMIMM14-IA25
Published: 09 October 2015
View article titled, Abstract IA25: Mechanisms of protective tumor immunity
Journal Articles

Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation

Eliezer M. Van Allen, Hadrien G. Golay, Yan Liu, Shohei Koyama, Karrie Wong, Amaro Taylor-Weiner, Marios Giannakis, Maegan Harden, Vanesa Rojas-Rudilla, Aaron Chevalier, Tran Thai, Christine Lydon, Stacy Mach, Ada G. Avila, Joshua A. Wong, Alexandra R. Rabin, Joshua Helmkamp, Lynette Sholl, Scott L. Carter, Geoffrey Oxnard, Pasi Janne, Gad Getz, Neal Lindeman, Peter S. Hammerman, Levi A. Garraway, F. Stephen Hodi, Scott J. Rodig, Glenn Dranoff, Kwok-Kin Wong, David A. Barbie
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2015) 3 (8): 855–863.
https://doi.org/10.1158/2326-6066.CIR-15-0024
Published: 03 August 2015
View article titled, Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with <em>JAK3</em> Activation
Open the PDF for Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with <em>JAK3</em> Activation in another window
Includes: Supplementary data